Morgan Stanley Has Lowered Expectations for Campbell’s (NASDAQ:CPB) Stock Price

Campbell’s (NASDAQ:CPBGet Free Report) had its price objective reduced by equities research analysts at Morgan Stanley from $25.00 to $23.00 in a report released on Thursday, Marketbeat Ratings reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 11.65% from the company’s current price.

CPB has been the topic of several other reports. Sanford C. Bernstein reduced their price objective on Campbell’s from $33.00 to $27.00 and set an “outperform” rating on the stock in a research note on Thursday, March 12th. Bank of America reduced their price objective on Campbell’s from $26.00 to $23.00 and set an “underperform” rating on the stock in a research note on Thursday, March 12th. DA Davidson reaffirmed a “neutral” rating and issued a $30.00 price objective on shares of Campbell’s in a research note on Thursday, March 12th. BTIG Research started coverage on Campbell’s in a research note on Monday, April 13th. They issued a “neutral” rating on the stock. Finally, Barclays reduced their price objective on Campbell’s from $23.00 to $21.00 and set an “underweight” rating on the stock in a research note on Tuesday, April 14th. Two research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and eight have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $26.39.

Check Out Our Latest Research Report on CPB

Campbell’s Stock Down 1.7%

CPB opened at $20.60 on Thursday. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.01 and a quick ratio of 0.51. The stock has a market capitalization of $6.14 billion, a price-to-earnings ratio of 11.26 and a beta of 0.03. The business has a 50-day moving average of $23.05 and a two-hundred day moving average of $26.97. Campbell’s has a 12 month low of $19.76 and a 12 month high of $36.80.

Campbell’s (NASDAQ:CPBGet Free Report) last posted its quarterly earnings results on Wednesday, March 11th. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.57 by ($0.06). The business had revenue of $2.56 billion during the quarter. Campbell’s had a net margin of 5.48% and a return on equity of 19.96%. Campbell’s’s revenue for the quarter was down 4.5% compared to the same quarter last year. During the same period last year, the business earned $0.74 EPS. Campbell’s has set its FY 2026 guidance at 2.150-2.250 EPS. On average, research analysts expect that Campbell’s will post 2.19 earnings per share for the current year.

Hedge Funds Weigh In On Campbell’s

Several hedge funds and other institutional investors have recently bought and sold shares of CPB. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Campbell’s by 3.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,472 shares of the company’s stock worth $777,000 after acquiring an additional 685 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in Campbell’s by 4.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 660,543 shares of the company’s stock worth $26,369,000 after acquiring an additional 27,374 shares in the last quarter. Empowered Funds LLC acquired a new position in Campbell’s during the 1st quarter worth approximately $446,000. Woodline Partners LP lifted its position in Campbell’s by 40.9% during the 1st quarter. Woodline Partners LP now owns 16,623 shares of the company’s stock worth $664,000 after acquiring an additional 4,827 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in Campbell’s by 333.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 975 shares of the company’s stock worth $39,000 after acquiring an additional 750 shares in the last quarter. 52.35% of the stock is owned by institutional investors and hedge funds.

Campbell’s Company Profile

(Get Free Report)

Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.

The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.

Read More

Analyst Recommendations for Campbell's (NASDAQ:CPB)

Receive News & Ratings for Campbell's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Campbell's and related companies with MarketBeat.com's FREE daily email newsletter.